Joint statement on ‘Abortion reversal’ by the Royal College of Obstetricians and Gynaecologists (RCOG), The Faculty of Sexual and Reproductive Healthcare (FSRH), the Royal College of Midwives (RCM) and the British Society of Abortion Care Providers (BSACP)
This CEU Statement provides guidance to healthcare professionals in response to a letter circulated by MSD (manufacturer of Nexplanon®) to healthcare professionals in the UK about updated guidance regarding the recommended Nexplanon® insertion site.
FSRH travel, accommodation and catering policy. Published September 2023.
This FSRH Statement provides guidance to support clinical practice during copper intrauterine shortages.
Clinical Director – FSRH Clinical Effectiveness Unit - Job Description
Systematic Reviewer (Researcher) – FSRH Clinical Effectiveness Unit- Job Description
Examiners Conference 2023 - Certificate of Attendance
15th September 2023
Here is the full-day agenda for the Examiners Conference 2023, taking place at RCOG Friday 15 September.
Member Support Fund Policy. Published September 2023.
This FSRH Statement responses to a recently published study by Meaidi et al. published on 06/09/2023 which used data from nationwide Danish databases to compare risk of first VTE events during use of hormonal contraception (HC) with that during concomitant use of HC and the non-steroidal anti-inflammatory drugs (NSAIDs) ibuprofen, diclofenac or naproxen.
View FAQs for our 2023 Annual Conference. Published September 2023.
Download the programme for the FSRH Annual Conference 2023. Published September 2023.
